The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment
Open accessAbstract
Enterobacter aerogenes and E. cloacae have been reported as important opportunistic and multiresistant bacterial pathogens for humans during the last three decades in hospital wards. These Gram-negative bacteria have been largely described during several outbreaks of hospital-acquired infections in Europe and particularly in France. The dissemination of Enterobacter sp. is associated with the presence of redundant regulatory cascades that efficiently control the membrane permeability ensuring the bacterial protection and the expression of detoxifying enzymes involved in antibiotic degradation/inactivation. In addition, these bacterial species are able to acquire numerous genetic mobile elements that strongly contribute to antibiotic resistance. Moreover, this particular fitness help them to colonize several environments and hosts and rapidly and efficiently adapt their metabolism and physiology to external conditions and environmental stresses. Enterobacter is a versatile bacterium able to promptly respond to the antibiotic treatment in the colonized patient. The balance of the prevalence, E. aerogenes versus E. cloacae, in the reported hospital infections during the last period, questions about the horizontal transmission of mobile elements containing antibiotic resistance genes, e.g., the efficacy of the exchange of resistance genes Klebsiella pneumoniae to Enterobacter sp. It is also important to mention the possible role of antibiotic use in the treatment of bacterial infectious diseases in this E. aerogenes/E. cloacae evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 2×
“The EefABC and AcrAB–TolC efflux genes of E. aerogenes have been described and their involvement in antibiotic exportation has been studied (Pradel and Pagès, 2002; Masi et al., 2005, 2006; Martins et al., 2010).”
BackgroundThe porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Self-citationBroad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Self-citationFarmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWhorter, A., Huntley-Carter, G. P., Asbury, M. A., Riddle, C., Wathen-Grady, H. G., Elias, C., & Fanning, G. R. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.21.1.46-76.1985 · Cited by 707
Structure of the AcrAB–TolC multidrug efflux pump
Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., & Luisi, B. F. (2014) · Nature · doi:10.1038/nature13205 · Cited by 662
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
Mezzatesta, M. L., Gona, F., & Stefani, S. (2012) · Future Microbiology · doi:10.2217/fmb.12.61 · Cited by 562
Enterobacter spp.: pathogens poised to flourish at the turn of the century
Sanders, W. E., & Sanders, C. C. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.220 · Cited by 532
Doumith, M., Ellington, M. J., Livermore, D. M., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp029 · Cited by 450
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Ectopic colonization of oral bacteria in the intestine drives T H 1 cell induction and inflammation
Atarashi, K., Suda, W., Luo, C., Kawaguchi, T., Motoo, I., Narushima, S., Kiguchi, Y., Yasuma, K., Watanabe, E., Tanoue, T., et al. (2017) · Science · doi:10.1126/science.aan4526 · Cited by 957
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance
Davin-Regli, A., Lavigne, J.-P., & Pagès, J.-M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-19 · Cited by 570
Self-citationLeonard, A. F. C., Zhang, L., Balfour, A. J., Garside, R., Hawkey, P. M., Murray, A. K., Ukoumunne, O. C., & Gaze, W. H. (2018) · Environment International · doi:10.1016/j.envint.2017.11.003 · Cited by 282
Enterobacter bugandensis: a novel enterobacterial species associated with severe clinical infection
Pati, N. B., Doijad, S. P., Schultze, T., Mannala, G. K., Yao, Y., Jaiswal, S., Ryan, D., Suar, M., Gwozdzinski, K., Bunk, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23069-z · Cited by 80
Al-Shaarani, A. A. Q. A., & Pecoraro, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1428415 · Cited by 50
Albuquerque, D. D. A., Figueiredo, F. B., Brandão, M. L., Furtado, M. C., Cordeiro, J. L. P., Lourenço, M. C. S., & Bruno, S. F. (2020) · Arquivo Brasileiro de Medicina Veterinária e Zootecnia · doi:10.1590/1678-4162-11507 · Cited by 3
Metadata
- Authors
- Davin-Regli, A., & Pagès, J.-M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2015-05-18
- Volume
- 6
- Pages
- 392-392
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W1848139833
- Cited by
- 627
- References
- 68
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.